Overview

Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly

Status:
Withdrawn
Trial end date:
2019-11-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if RTB101 prevents illness associated with respiratory tract infections in people ≥65 years of age.
Phase:
Phase 3
Details
Lead Sponsor:
Restorbio Inc.
Treatments:
Dactolisib